Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Chuong MD, Clark MA, Henke LE, Kishan AU, Portelance L, Parikh PJ, Bassetti MF, Nagar H, Rosenberg SA, Mehta MP, Refaat T, Rineer JM, Smith A, Seung S, Zaki BI, Fuss M, Mak RH. Chuong MD, et al. Among authors: nagar h. Clin Transl Radiat Oncol. 2022 Nov 22;38:161-168. doi: 10.1016/j.ctro.2022.11.013. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36466748 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34701626
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer.
Roy S, Zaorsky NG, Bagshaw HP, Berlin A, Tree A, Turner S, Koontz B, Nguyen P, Chen R, Dess RT, Jackson WC, Kishan AU, Stish B, Nagar H, Posadas E, Tran PT, Solanki A, Shore ND, Guo G, Ponsky L, Shoag JE, Morgans AK, Garcia JA, Showalter TN, Feng FY, Spratt DE. Roy S, et al. Among authors: nagar h. Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):278-289. doi: 10.1016/j.ijrobp.2021.12.005. Epub 2021 Dec 17. Int J Radiat Oncol Biol Phys. 2022. PMID: 34923058 Review.
Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.
Smith CP, Proudfoot JA, Boutros PC, Reiter RE, Valle L, Rettig MB, Nickols NG, Feng FY, Nguyen PL, Nagar H, Spratt DE, Attard G, Weiner A, Weidhaas JB, Calais J, Ma TM, Davicioni E, Xiang M, Kishan AU. Smith CP, et al. Among authors: nagar h. Eur Urol Oncol. 2023 Apr;6(2):224-227. doi: 10.1016/j.euo.2023.02.009. Epub 2023 Mar 2. Eur Urol Oncol. 2023. PMID: 36870853
[No title available]
[No authors listed] [No authors listed] PMID: 37785281
[No title available]
[No authors listed] [No authors listed] PMID: 37785390
[No title available]
[No authors listed] [No authors listed] PMID: 37785459
174 results